ALORA — FDA application NDA020655

Application NDA020655 · type NDA · FDA status: approved · original approval 1996-12-20

Listed sponsor: ABBVIE · ABBV company profile · exact_unique

Sponsor as listed in Drugs@FDA at retrieval (2026-08-07); FDA sponsor listings can lag ownership transfers.

FDA application facts

Product	FDA-listed trade name	Active ingredient	Dosage form	Route	Strength	Marketing status	TE code	RLD
001	ALORA	ESTRADIOL	FILM, EXTENDED RELEASE	TRANSDERMAL	0.05MG/24HR	Discontinued	not listed	No
002	ALORA	ESTRADIOL	FILM, EXTENDED RELEASE	TRANSDERMAL	0.075MG/24HR	Discontinued	not listed	No
003	ALORA	ESTRADIOL	FILM, EXTENDED RELEASE	TRANSDERMAL	0.1MG/24HR	Discontinued	not listed	No
004	ALORA	ESTRADIOL	FILM, EXTENDED RELEASE	TRANSDERMAL	0.025MG/24HR	Discontinued	not listed	No

Product, form, strength, reference-drug and marketing-status fields: Drugs@FDA data files; TE and RLD fields: Orange Book data files. Retrieved 2026-08-07.

No Orange Book patent or exclusivity listings joined to this application.

Ingredient–compound links use FDA openFDA/GSRS identifiers and an exact lmmol InChIKey join. Ingredient names cannot create a link.

Sources: Drugs@FDA · Orange Book · openFDA application record. FDA data retrieved 2026-08-07.

Regulatory listing data as published by FDA; not medical or investment advice.